Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2005
11/03/2005WO2005055936A3 Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells
11/03/2005WO2005050215A8 Selection of lactic acid bacteria enhancing the immune response against streptococcus pneumoniae
11/03/2005WO2005050202A3 Biological materials and uses thereof
11/03/2005WO2005049056A3 Immune modulator comprising whole cell rhodococcus, gordonia, nocardia, dietzia, tsukamurella or nocardioides bacteria
11/03/2005WO2005046657A3 Use of an inhibitor of csf-1 activity for the treatment of inflammatory bowel disease
11/03/2005WO2005046597A3 Antibodies to cd44 glycoforms and uses thereof
11/03/2005WO2005046454A3 Methods of using gelsolin to treat or prevent bacterial sepsis
11/03/2005WO2005044998A3 Enhanced b cell cytotoxicity of cdim binding antibody
11/03/2005WO2005032582A3 Immunogenic compositions for streptococcus pyogenes
11/03/2005WO2005020927A3 Method of promoting graft survival with anti-tissue factor antibodies
11/03/2005WO2005009396A3 Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
11/03/2005WO2005005651A3 T cell receptor sequence and method for detecting and treating rheumatoid arthritis
11/03/2005WO2005000240A3 Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis
11/03/2005WO2004108070A3 Releasable polymeric conjugates based on aliphatic biodegradable linkers
11/03/2005WO2003074551A8 Conjugates of therapeutic or cytotoxic agents and biologically active peptides
11/03/2005US20050245477 Immunomodulatory oligonucleotides
11/03/2005US20050245471 Combination products for use in antitumoral treatment
11/03/2005US20050245467 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
11/03/2005US20050245454 Methods and compositions for impairing multiplication of HIV-1
11/03/2005US20050244899 Laminin Receptor 1 Precursor Protein (37LRP) epitope delineated by an Hepatocellular carcinoma specific antibody
11/03/2005US20050244896 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
11/03/2005US20050244877 Splice variants of CD40-receptor
11/03/2005US20050244828 Elisa assay of serum soluble cd22 to assess tumor burnden/relapse in subjects with leukemia and lymphoma
11/03/2005US20050244826 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or wnt
11/03/2005US20050244823 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
11/03/2005US20050244817 Mammalian genes involved in viral infection and tumor suppression
11/03/2005US20050244505 Immunotherapy compositions, method of making and method of use thereof
11/03/2005US20050244472 Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
11/03/2005US20050244436 Combination Neisserial compositions
11/03/2005US20050244435 Comprises clostridial neurotoxin light chain domains; endopeptidases; vaccines; fusion proteins; for inhibiting exocytosis
11/03/2005US20050244434 Tat-based tolerogen compositions and methods of making and using same
11/03/2005US20050244433 Administering vaccine comprising human papillomavirus L1 protein and excludes E protein to induce immune response
11/03/2005US20050244432 Expression of an L1 protein or functional protein derivative from two different types of papillomaviruses, and mixing the two; used for the prevention or treatment of a disease related to papillomavirus infection, such as cervical cancer or genital warts
11/03/2005US20050244431 Recombinant herpesvirus and polyvalent vaccine
11/03/2005US20050244430 Orthopoxvirus vectors, genes and products thereof
11/03/2005US20050244429 Live replicating spumavirus vector
11/03/2005US20050244428 Site-directed mutagenesis; plasmid vectors; Dengue virus
11/03/2005US20050244425 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
11/03/2005US20050244424 Carbohydrate-based synthetic vaccines for hiv
11/03/2005US20050244423 administering to mammals genetic engineered or pegylated polypeptides, to reduce liver inflammation associated with viral infections
11/03/2005US20050244422 Methods for delivering MBD peptide-linked agent into cells under conditions of cellular stress
11/03/2005US20050244421 Compositions and methods for modulating immune response
11/03/2005US20050244420 comprising a liquid solution consisting of an immunogenic substance and magnesium carbonate hydroxide pentahydrate, used for generating an immune response
11/03/2005US20050244419 Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
11/03/2005US20050244418 Recombinant tumor specific antibody and use thereof
11/03/2005US20050244417 Using mixture comprising human estrogen specific immunoglobulin and tumor necrosis factor related apoptosis inducing ligand (APO-2L) for use as tool to enhance apoptosis in cancer cells
11/03/2005US20050244415 administering an antibody which recognizes an extracellular domain of signal regulatory protein-beta (SIRP-beta); treatment of infections or cancer
11/03/2005US20050244414 Method to ameliorate osteolysis and metastasis
11/03/2005US20050244413 Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and chemotherapeutic agents
11/03/2005US20050244412 Method and composition for regulating activity of regulatory T cells
11/03/2005US20050244411 BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
11/03/2005US20050244410 Toll-like receptor 9 effector agents and uses thereof
11/03/2005US20050244409 Erythropoietin receptor antibodies
11/03/2005US20050244408 gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-IGF-IR antibodies; colorectal or breast cancer tumor
11/03/2005US20050244407 Therapeutic synergy of anti-cancer compounds
11/03/2005US20050244406 Monoclonal antibodies against extracellular loops of c5ar
11/03/2005US20050244405 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis
11/03/2005US20050244404 Methods of donor specific crossmatching
11/03/2005US20050244403 Diagnosis and therapy, antibody variant
11/03/2005US20050244386 Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell
11/03/2005US20050244385 Intradermal cellular delivery using narrow gauge micro-cannula
11/03/2005US20050244380 Immunomodulatory oligonucleotides
11/03/2005US20050244379 Using oligonucleotide complexes comprising phosphorothioate backbone to enhance antigen-specific immune response; antisense therapies; gene expression inhibition; viricides
11/03/2005US20050244374 Enveloped miroorganism
11/03/2005US20050244371 Treating cancer using ultrapheresis; tissue necrosis factor receptor-2 (TNFR-2);
11/03/2005US20050244336 Diagnostic method for atherosclerosis
11/03/2005US20050244333 That combine a binding site recognizing the same epitope as T84.66 and a polypeptide framework of a human or humanized antibody; exhibit binding affinity and specificity for carcinoembryonic antigen nearly identical to that of T84.66 and the ability to specifically target tumors expressing CEA
11/03/2005DE102004011776A1 Trägersystem in Form von Nanopartikeln auf Proteinbasis zur zellspezifischen Anreicherung von pharmazeutisch aktiven Wirkstoffen Carrier system in the form of nanoparticles protein-based cell-specific enrichment of active pharmaceutical ingredients
11/03/2005CA2567748A1 Poly-n-acetyl glucosamine (pnag/dpnag)-binding peptides and methods of use thereof
11/03/2005CA2566509A1 Immunising against meningococcal serogroup y using proteins
11/03/2005CA2564562A1 Adjuvant composition and methods for its use
11/03/2005CA2564453A1 Peptide inhibitors of metalloproteinase activity
11/03/2005CA2564180A1 Pharmaceutical preparation containing bacterial cell wall skeleton component
11/03/2005CA2564137A1 Treatment of fungal infections
11/03/2005CA2562764A1 Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo
11/03/2005CA2562642A1 Apparatus and method for transdermal delivery of multiple vaccines
11/03/2005CA2561065A1 Therapeutic use of anti-cs1 antibodies
11/02/2005EP1591537A2 Hereditary hemochromatosis gene
11/02/2005EP1591530A2 A tumor necrosis factor related ligand
11/02/2005EP1591456A1 Antibodies for cancer therapy and diagnosis
11/02/2005EP1591128A1 Thymosin beta 4 promotes wound repair
11/02/2005EP1590459A2 Methods for increasing neisseria protein expression and compositions thereof
11/02/2005EP1590440A2 Cell-killing molecules and methods of use thereof
11/02/2005EP1590435A2 Depletion of endogenous primordial germ cels in avian species
11/02/2005EP1590434A2 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
11/02/2005EP1590432A2 Dna compositon and uses thereof
11/02/2005EP1590431A2 TNF-a BINDING MOLECULES
11/02/2005EP1590372A2 Trimeric polypeptide construct to induce an enduring t cell response
11/02/2005EP1590365A2 Mycobacterial diagnostics
11/02/2005EP1589998A2 Uses of mammalian cytokine; related reagents
11/02/2005EP1589996A2 Anti-integrin alpha beta 3 antibody formulat ions and uses thereof
11/02/2005EP1589994A2 Composition and method for preventing or treating a virus infection
11/02/2005EP1589990A2 Method for treating cancer in humans
11/02/2005EP1589985A2 Methods and compositions in treating pain and painful disorders using 16386, 15402, 21165, 1423, 636, 12303, 21425, 27410, 38554, 38555, 55063, 57145, 59914, 94921, 16852, 33260, 58573, 30911, 85913, 14303, 16816, 17827 or 32620
11/02/2005EP1589943A2 Methods of treating lung diseases
11/02/2005EP1589933A2 Compositions and methods for the diagnosis and treatment of tumor
11/02/2005EP1444261B1 Immunogenic alk (anaplastic lymphoma kinase) peptides
11/02/2005EP1357930B1 Histidine-rich glycoprotein (hrgp) for inhibiting angiogenesis
11/02/2005EP1212334B1 Oligosaccharides derived from ribose-ribitol-phosphate, and vaccines containing them
11/02/2005EP1200563B1 Attenuated influenza virus useful as vaccine
1 ... 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 ... 1823